Moderators: Andrew Hart (Glasgow, Scotland) Daniel Kalbermatten (Geneva, Switzerland)
2. “Most cited paper of year to date - Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction" Peter Cordeiro (New York,USA)
3. “2nd most cited paper of year to date - Autologous versus implant-based breast reconstruction A systematic review and meta-analysis of Breast-Q patient-reported outcomes" Navid Toyserkani (Odense, Denmark) and Jens Sørensen (Odense, Denmark)
4."Greatest mixed metric impact of year to date - Moving breast implant registries forward – are they FAIR and Functional?" Hinne Rakhorst (Enschede, Netherlands)
5.The governance of overseas collaborations - BFIRST/BSSH - Barbara Jemec (Toronto, Canada)
